301 related articles for article (PubMed ID: 10596683)
1. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease.
Soler N; Ewig S; Torres A; Filella X; Gonzalez J; Zaubet A
Eur Respir J; 1999 Nov; 14(5):1015-22. PubMed ID: 10596683
[TBL] [Abstract][Full Text] [Related]
2. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.
Sethi S; Maloney J; Grove L; Wrona C; Berenson CS
Am J Respir Crit Care Med; 2006 May; 173(9):991-8. PubMed ID: 16474030
[TBL] [Abstract][Full Text] [Related]
3. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD.
Rutgers SR; Timens W; Kaufmann HF; van der Mark TW; Koëter GH; Postma DS
Eur Respir J; 2000 Jan; 15(1):109-15. PubMed ID: 10678630
[TBL] [Abstract][Full Text] [Related]
4. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1.
O'Shaughnessy TC; Ansari TW; Barnes NC; Jeffery PK
Am J Respir Crit Care Med; 1997 Mar; 155(3):852-7. PubMed ID: 9117016
[TBL] [Abstract][Full Text] [Related]
5. Lower airway bacterial colonization in asymptomatic smokers and smokers with chronic bronchitis and recurrent exacerbations.
Qvarfordt I; Riise GC; Andersson BA; Larsson S
Respir Med; 2000 Sep; 94(9):881-7. PubMed ID: 11001080
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease.
Pesci A; Balbi B; Majori M; Cacciani G; Bertacco S; Alciato P; Donner CF
Eur Respir J; 1998 Aug; 12(2):380-6. PubMed ID: 9727789
[TBL] [Abstract][Full Text] [Related]
7. Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.
Gasiuniene E; Lavinskiene S; Sakalauskas R; Sitkauskiene B
COPD; 2016 Oct; 13(5):569-75. PubMed ID: 27018873
[TBL] [Abstract][Full Text] [Related]
8. Partial divergence of cytokine mRNA expression in bronchial tissues compared to bronchoalveolar lavage cells in horses with recurrent airway obstruction.
Riihimäki M; Raine A; Art T; Lekeux P; Couëtil L; Pringle J
Vet Immunol Immunopathol; 2008 Apr; 122(3-4):256-64. PubMed ID: 18243337
[TBL] [Abstract][Full Text] [Related]
9. Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD.
Wen Y; Reid DW; Zhang D; Ward C; Wood-Baker R; Walters EH
Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():327-34. PubMed ID: 21037956
[TBL] [Abstract][Full Text] [Related]
10. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.
Zalacain R; Sobradillo V; Amilibia J; Barrón J; Achótegui V; Pijoan JI; Llorente JL
Eur Respir J; 1999 Feb; 13(2):343-8. PubMed ID: 10065679
[TBL] [Abstract][Full Text] [Related]
11. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
Keatings VM; Collins PD; Scott DM; Barnes PJ
Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092
[TBL] [Abstract][Full Text] [Related]
12. Decreased cytokine and chemokine mRNA expression in bronchoalveolar lavage in asymptomatic smoking subjects.
Meuronen A; Majuri ML; Alenius H; Mäntylä T; Wolff H; Piirilä P; Laitinen A
Respiration; 2008; 75(4):450-8. PubMed ID: 18230951
[TBL] [Abstract][Full Text] [Related]
13. Severity of airflow limitation is associated with severity of airway inflammation in smokers.
Di Stefano A; Capelli A; Lusuardi M; Balbo P; Vecchio C; Maestrelli P; Mapp CE; Fabbri LM; Donner CF; Saetta M
Am J Respir Crit Care Med; 1998 Oct; 158(4):1277-85. PubMed ID: 9769292
[TBL] [Abstract][Full Text] [Related]
14. Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis.
Linden M; Rasmussen JB; Piitulainen E; Tunek A; Larson M; Tegner H; Venge P; Laitinen LA; Brattsand R
Am Rev Respir Dis; 1993 Nov; 148(5):1226-32. PubMed ID: 8239158
[TBL] [Abstract][Full Text] [Related]
15. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
[TBL] [Abstract][Full Text] [Related]
16. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease.
Di Stefano A; Caramori G; Capelli A; Gnemmi I; Ricciardolo FL; Oates T; Donner CF; Chung KF; Barnes PJ; Adcock IM
Eur Respir J; 2004 Jul; 24(1):78-85. PubMed ID: 15293608
[TBL] [Abstract][Full Text] [Related]
17. Ongoing airway inflammation in patients with COPD who do not currently smoke.
Rutgers SR; Postma DS; ten Hacken NH; Kauffman HF; van Der Mark TW; Koëter GH; Timens W
Thorax; 2000 Jan; 55(1):12-8. PubMed ID: 10607796
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of placenta growth factor in COPD.
Cheng SL; Wang HC; Yu CJ; Yang PC
Thorax; 2008 Jun; 63(6):500-6. PubMed ID: 18202163
[TBL] [Abstract][Full Text] [Related]
19. Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects.
Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
Clin Exp Immunol; 2007 Oct; 150(1):22-9. PubMed ID: 17614970
[TBL] [Abstract][Full Text] [Related]
20. Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization.
Sibila O; Garcia-Bellmunt L; Giner J; Rodrigo-Troyano A; Suarez-Cuartin G; Torrego A; Castillo D; Solanes I; Mateus EF; Vidal S; Sanchez-Reus F; Sala E; Cosio BG; Restrepo MI; Anzueto A; Chalmers JD; Plaza V
Ann Am Thorac Soc; 2016 May; 13(5):636-42. PubMed ID: 26882402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
